Gene Express, Inc. - Product Pipeline Analysis by GlobalData

VIEWS: 30 PAGES: 26

More Info
									                                              Gene Express, Inc. - Product Pipeline Analysis
     Reference Code: GDME7668PD                                                                                           Publication Date: NOV 2010



     Company Snapshot                                                         Company Overview
     Key Information
                                                                              Gene Express, Inc. (Gene Express) is principally engaged in the
      Gene Express, Inc., Key Facts                                           development and marketing of molecular diagnostic products and
                                                                              standardizes multi-gene expression measurement. It develops patented
      Web Address                           www.geneexpressinc.com
                                                                              Standardized Mixtures of Internal Standards known as SMIS. The
      Industry                              Pharmaceuticals and Healthcare-   company utilizes a proprietary technology known as StaRT-PCR
      Source:Primary / Secondary Research                                     (Standardized Reverse Transcriptase Polymerase Chain Reaction) to
      GlobalData                                                              standardize multi-gene Transcript Abundance (TA) measurement.



     Gene Express, Inc. Pipeline Products

      Gene Express, Inc. Key Pipeline Products by Equipment                   Gene Express, Inc. Key Pipeline Products by Therapy Area
      Type
     Equipment Type                              No of Products               Therapy Area                                          No of Products
     Immuno Chemistry                                6                        Lung cancer                                               3
     Genetic Testing                                                  2       Tumor                                                     2
     Source: Primary / Secondary Research                                     Bladder cancer                                            1
     GlobalData
                                                                              Chronic myelogenous leukemia                              1
                                                                              Myeloid neoplasia                                         1
                                                                              Source: Primary / Secondary Research
                                                                              GlobalData


     Gene Express, Inc. Key Pipeline Products by Equipment Type




      Source: Primary / Secondary Research
      GlobalData




     Gene Express, Inc. Key Pipeline Products by Development                  Gene Express, Inc. Key Pipeline Products by Trial Phase
     Stage
     Developmental Stage                        No of Products                Trial Phase                                           No of Products
     Clinicals                                   7                            Phase IV                                          -
     Pre-Clinicals                                                -           Phase III                                         -
     Early development                                           1            Phase II                                          -
     No Specific Phase                                           1            Phase I                                           -
     Source: Primary / Secondary Research                                     Source: Primary / Secondary Research
     GlobalData                                                               GlobalData
     Note : (-) indicates 'Not Available'                                     Note : (-) indicates 'Not Available'




Gene Express, Inc. - Product Pipeline Analysis                                                                                Reference Code: GDME7668PD

Source : www.globalcompanyintelligence.com                                                                                                             Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 3
     Gene Express, Inc. - Business Description............................................................................................................................................................................................................................ 4
     Key Facts ............................................................................................................................................................................................................................................................................... 5
     Gene Express, Inc. - Major Products and Services ............................................................................................................................................................................................................... 6
           Gene Express, Inc. Pipeline Products by Equipment Type ............................................................................................................................................................................................. 7
           Gene Express, Inc. Pipeline Products by Development Stage........................................................................................................................................................................................ 9
           Gene Express, Inc. Pipeline Products by Therapy Area ............................................................................................................................................................................................... 11
           Gene Express, Inc. Pipeline Products by Trial Phase ................................................................................................................................................................................................... 13
           Cisplatin Chemoresistance Test .................................................................................................................................................................................................................................... 15
                 Product Status......................................................................................................................................................................................................................................................... 15
                 Product Description ................................................................................................................................................................................................................................................. 15
                 Product Milestone ................................................................................................................................................................................................................................................... 15
           Irinotecan (CPT-11) Chemoresistance Test .................................................................................................................................................................................................................. 16
                 Product Status......................................................................................................................................................................................................................................................... 16
                 Product Description ................................................................................................................................................................................................................................................. 16
           JAK–Myeloid Neoplasia Test......................................................................................................................................................................................................................................... 16
                 Product Status......................................................................................................................................................................................................................................................... 16
                 Product Description ................................................................................................................................................................................................................................................. 16
           Lung Cancer Diagnostic assay ...................................................................................................................................................................................................................................... 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
           LungSentryDx ...........................................................................................................................................
								
To top